Citations for
1HHLA2, TMIGD2
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families.
Janakiram M, Chinai JM, Zhao A, Sparano JA, Zang X.
Oncoimmunology 4(8):e1026534. eCollection 2015 Aug. 2015
2HHLA2, TMIGD2
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
Janakiram M, Chinai JM, Fineberg S, Fiser A, Montagna C, Medavarapu R, Castano E, Jeon H, Ohaegbulam KC, Zhao R, Zhao A, Almo SC, Sparano JA, Zang X.
Clin Cancer Res 21(10):2359-66. doi: 10.1158/1078-0432.CCR-14-1495. Epub 2014 Dec 30. 2015
3C10orf54, TMIGD2
B7-H5 costimulates human T cells via CD28H.
Zhu Y, Yao S, Iliopoulou BP, Han X, Augustine MM, Xu H, Phennicie RT, Flies SJ, Broadwater M, Ruff W, Taube JM, Zheng L, Luo L, Zhu G, Chen J, Chen L.
Nat Commun 4:2043. doi: 10.1038/ncomms3043. 2013
4TMIGD2
Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis.
Rahimi N, Rezazadeh K, Mahoney JE, Hartsough E, Meyer RD.
Mol Biol Cell 23(9):1646-56. doi: 10.1091/mbc.E11-11-0934. Epub 2012 Mar 14. 2012